An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT02750514 · TERMINATED
Trial details
- NCT number
- NCT02750514
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2020-01-29
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.